TB Vaccine Offers Clue To Shape Immunity Against Alzheimer’s, Pg11

Key Highlights:

• A study suggests the Bacillus Calmette-Guérin (BCG) vaccine, traditionally used for tuberculosis, may offer clues to shaping immunity against Alzheimer’s disease.
• Researchers at Massachusetts General Hospital found that BCG induced trained immunity-like responses within the central nervous system of older adults.
• The vaccine appeared to help clear amyloid-beta from the brain into the blood in participants without established Alzheimer’s.
• BCG led to a calming state in the cerebrospinal fluid across the blood-brain barrier, despite triggering inflammatory signals in blood plasma.

BCG Vaccine.jpg

Detailed Insights:

• The aging immune system often enters a state of chronic, low-grade inflammation known as inflammaging, which is particularly damaging to the brain.
• Inflammaging causes immune cells to become dysfunctional, hindering their ability to clear toxic amyloid-beta plaques associated with Alzheimer’s disease.
• Trained immunity is a phenomenon where certain vaccines provide innate immune cells with a long-lasting memory, enhancing their response to unrelated threats.
• The study observed that monocytes in the cerebrospinal fluid activated genes linked to a faster, more alert immune response after BCG vaccination.
• While the vaccine showed potential for amyloid-beta clearance in early stages, it did not materialize in participants with established Alzheimer’s, possibly due to an overwhelmed immune system or a damaged blood-brain barrier.
• The study, involving 23 participants, was primarily designed to understand the biological effects of BCG and highlighted its plausible utility as a preventive measure rather than a treatment for advanced Alzheimer's.
• BCG is a cost-effective vaccine with extensive safety data, offering a potential alternative to expensive modern anti-amyloid drugs.

Scientific/Technical Concepts Involved:

• Inflammaging: Chronic, low-grade inflammation associated with aging, contributing to various age-related diseases.
• Amyloid-beta: A protein fragment that can accumulate in the brain, forming plaques characteristic of Alzheimer's disease.
• Trained immunity: The ability of innate immune cells to develop a long-term memory after exposure to certain stimuli, leading to enhanced responses to subsequent infections.
• Blood-brain barrier: A highly selective semipermeable border that separates the circulating blood from the brain and extracellular fluid in the central nervous system.